India delays big exports of AstraZeneca vaccine – report


India will keep the vaccines at home

Reuters, citing sources, reports that India is delaying big shipments of the AstraZeneca vaccine as cases surge at home.

Here’s a look at the case count in India and you can imagine how many cases go unreported in  country that big and that poor.

Meanwhile, in Italy, AstraZeneca is under fire for around 30m vaccine doses sitting in its facilities. The company now says they’re waiting quality control.

There’s plenty of good news in the US, UK and other rich countries on vaccine hospitalizations and deaths but there’s a good argument that that broader souring in markets is about slow vaccine rollouts and more-infections variants.

The vast majority of countries are about to get hit hard, crimping global demand, especially for commodities.

Invest in yourself. See our forex education hub.

Articles You May Like

UK inflation data continues to pile on the pressure on the BOE
NZD/USD Price Analysis: Bulls moving in for possible run towards trendline resistance
Best TIMEFRAME for Option Buyers
Gold holds steady on caution over US debt talks
Dollar mildly lower with PCE price data in focus today